Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Enrolling by invitation × Neoplasm, Residual × Clear all

Phase

Status

Completed 4 Unknown 3 Recruiting 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Lymphedema 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myeloid, Acute 1 Cholangiocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07537257 2026-04-17

VEN+IDAC vs IDAC in AML

Guangdong Second Provincial General Hospital

Phase 2/3 Enrolling by invitation

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡